Soligenix Enters Into Exclusive Option Agreement With Silk Road Therapeutics For Rights To Topical Pentoxifylline Designed To Treat Behçet's Disease
Soligenix Enters Into Exclusive Option Agreement With Silk Road Therapeutics For Rights To Topical Pentoxifylline Designed To Treat Behçet's Disease
Soligenix 与 Silk Road Therapeutics 签订独家期权协议,以获得旨在治疗白塞氏病的局部用己酮可可碱的权利
Soligenix Enters into Exclusive Option Agreement With Silk Road Therapeutics For Rights To Topical Pentoxifylline Designed To Treat Behçet's Disease
Soligenix 与 Silk Road Therapeutics 签订独家期权协议,以获得旨在治疗 Beh√βset 病的局部用己酮可可碱的权利